Talvey

Active Ingredient(s): Talquetamab-tgvs
FDA Approved: * August 9, 2023
Pharm Company: * JANSSEN BIOTECH
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Talvey 3 mg/1.5ml Subcutaneous Injection
NDC: 57894-469
Labeler:
Janssen Biotech, Inc.
Talvey 40 mg/ml Subcutaneous Injection
NDC: 57894-470
Labeler:
Janssen Biotech, Inc.